Skip to Content
Authors Martin FM, Rossi RL, Nugent FW, Scholz FJ, Jenkins RL, Lewis WD, Gagner M, Foley E, Braasch JW
Author Profile(s)
Journal Ann. Surg. Volume: 212 Issue: 4 Pages: 551-6; discussion 556-8
Publish Date 1990 Oct
PubMed ID 2222020
PMC ID 1358296

Of 178 patients with sclerosing cholangitis treated since 1950, 88 patients had associated inflammatory bowel disease, 72 had no such history, and 18 had iatrogenic injury or stone disease. A total of 233 biliary operations were performed, with a 75% rate of temporary improvement after initial operation. Subsequent operations resulted in a lower success rate and a higher mortality rate. Radiologic findings included predominant extrahepatic, intrahepatic, and diffuse disease in 29%, 28%, and 43% of patients, respectively; no survival differences were noted. Seventy-five of one hundred three deaths (73%) were related to liver failure, bleeding, or sepsis. Of 14 patients undergoing portosystemic shunt, 13 died of surgical complications or related disease. Orthotopic liver transplantation was performed in 16 patients and resulted in eight deaths, mainly in patients who had previously undergone extensive surgical treatment. No survival differences were seen between the patients with inflammatory bowel disease, those without the condition, or those who had colectomy. Surgical treatment in patients with sclerosing cholangitis should be minimized. Orthotopic liver transplantation should be offered as the treatment of choice for patients with portal hypertension, refractory cholangitis, advanced cirrhosis, or progressive liver failure.

Full Text Full text available on PubMed Central Copyright © 2017 The Board of Regents of the University of Wisconsin System